Insulet Corporation [PODD] stock is trading at $261.63, up 2.42%. An important factor to consider is whether the stock is rising or falling in short-term value. The PODD shares have gain 10.36% over the last week, with a monthly amount drifted -7.26%, and not seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Insulet Corporation [NASDAQ: PODD] stock has seen the most recent analyst activity on March 06, 2025, when RBC Capital Mkts initiated its Outperform rating and assigned the stock a price target of $340. Previously, Bernstein started tracking the stock with Outperform rating on November 06, 2024, and set its price target to $300. On May 30, 2024, Redburn Atlantic initiated with a Buy rating and assigned a price target of $235 on the stock. Wolfe Research upgraded its rating to a Outperform but stick to its price target of $200 on May 07, 2024. Robert W. Baird upgraded its rating to a Outperform and raised its price target to $238 on December 21, 2023. Morgan Stanley upgraded its rating to Overweight for this stock on December 04, 2023, and upped its price target to $234. In a note dated October 02, 2023, Jefferies upgraded an Buy rating on this stock and revised its target price from $260 to $240.
Insulet Corporation [PODD] stock has fluctuated between $160.19 and $289.46 over the past year. Currently, Wall Street analysts expect the stock to reach $276.67 within the next 12 months. Insulet Corporation [NASDAQ: PODD] shares were valued at $261.63 at the most recent close of the market. An investor can expect a potential return of 5.75% based on the average PODD price forecast.
Analyzing the PODD fundamentals
Insulet Corporation [NASDAQ:PODD] reported sales of 2.07B for the trailing twelve months, which represents a growth of 17.20%. Gross Profit Margin for this corporation currently stands at 0.76% with Operating Profit Margin at 0.16%, Pretax Profit Margin comes in at 0.16%, and Net Profit Margin reading is 0.22%. To continue investigating profitability, this company’s Return on Assets is posted at 0.14, Equity is 0.41 and Total Capital is 0.12. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.07.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 255.24 points at the first support level, and at 248.85 for the second support level. However, for the 1st resistance point, the stock is sitting at 265.25, and for the 2nd resistance point, it is at 268.87.
Ratios To Look Out For
For context, Insulet Corporation’s Current Ratio is 3.54. On the other hand, the Quick Ratio is 2.73, and the Cash Ratio is 1.8. Considering the valuation of this stock, the price to sales ratio is 8.87, the price to book ratio is 15.16 and price to earnings (TTM) ratio is 45.20.
Transactions by insiders
Recent insider trading involved Benjamin Eric, EVP, CPXPO, that happened on Jan 21 ’25 when 12394.0 shares were sold. Officer, Benjamin Eric completed a deal on Jan 21 ’25 to buy 12394.0 shares. Meanwhile, EVP, CPXPO Benjamin Eric sold 4362.0 shares on Dec 16 ’24.
